“…Furthermore, soluble interleukin-2 receptor (sIL-2R), which is a known indicator of disease activity in LCH, was within the normal range at the time of the preoperative examination, and CT, MRI, and bone scintigraphy did not show any osteolytic changes in the skull defect. There has been a case report describing a good outcome after a 1-stage cranioplasty using a split calvarial bone graft for a skull defect that occurred after removal of a skull lesion in a patient with single-system unifocal-type LCH 7 . However, in our patient, bone was grafted onto the remaining bone defect after chemotherapy and not after removal of the lesion.…”